IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival

2001 ◽  
Vol 37 (4) ◽  
pp. 478-485 ◽  
Author(s):  
D. Katsaros ◽  
H. Yu ◽  
M.A. Levesque ◽  
S. Danese ◽  
F. Genta ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Patient Survival ◽  
Epithelial Ovarian Carcinoma ◽  
Pathological Features ◽  
Igfbp 3

scholarly journals Immunological configuration of ovarian carcinoma: features and impact on disease outcome

2021 ◽  
Vol 9 (10) ◽  
pp. e002873
Author(s):  
Jitka Fucikova ◽  
An Coosemans ◽  
Sandra Orsulic ◽  
David Cibula ◽  
Ignace Vergote ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Immune Cells ◽  
Malignant Disease ◽  
Patient Survival ◽  
Checkpoint Inhibitors ◽  
Epithelial Ovarian Carcinoma ◽  
Disease Outcome ◽  
Rare Malignancy ◽  
Other Neoplasms ◽  
Treatment Sensitivity

Epithelial ovarian carcinoma (EOC) is a relatively rare malignancy but is the fifth-leading cause of cancer-related death in women, largely reflecting early, prediagnosis dissemination of malignant disease to the peritoneum. At odds with other neoplasms, EOC is virtually insensitive to immune checkpoint inhibitors, correlating with a tumor microenvironment that exhibits poor infiltration by immune cells and active immunosuppression. Here, we comparatively summarize the humoral and cellular features of primary and metastatic EOC, comparatively analyze their impact on disease outcome, and propose measures to alter them in support of treatment sensitivity and superior patient survival.

C-Fos Expression as Predictor of Progression and Survival in Epithelial Ovarian Carcinoma

2008 ◽  
Vol 68 (S 01) ◽  
Author(s):  
S Mahner ◽  
C Baasch ◽  
J Schwarz ◽  
L Wölber ◽  
F Jänicke ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Epithelial Ovarian Carcinoma ◽  
Fos Expression

scholarly journals Involvement of SDF-1α/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma

2007 ◽  
Vol 122 (1) ◽  
pp. 91-99 ◽  
Author(s):  
Hiroaki Kajiyama ◽  
Kiyosumi Shibata ◽  
Mikio Terauchi ◽  
Kazuhiko Ino ◽  
Akihiro Nawa ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Peritoneal Metastasis ◽  
Epithelial Ovarian Carcinoma ◽  
Cxcr4 Axis

Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival

2021 ◽  
Vol 162 ◽  
pp. S124
Author(s):  
Dimitrios Nasioudis ◽  
Spyridon Mastroyannis ◽  
Emily Ko ◽  
Ashley Haggerty ◽  
Lori Cory ◽  
...  
Keyword(s):  
Adjuvant Chemotherapy ◽  
Ovarian Carcinoma ◽  
Figo Stage ◽  
Epithelial Ovarian Carcinoma ◽  
Stage I ◽  
Chemotherapy Administration

8049 POSTER Epithelial Ovarian Carcinoma in Very Young Women: Age-specific Characteristics

2011 ◽  
Vol 47 ◽  
pp. S542
Author(s):  
J. Michels ◽  
A. Rey ◽  
P. Duvillard ◽  
P. Morice ◽  
O. Caron ◽  
...  
Keyword(s):  
Ovarian Carcinoma ◽  
Young Women ◽  
Epithelial Ovarian Carcinoma
Sign in / Sign up

Export Citation Format

Share Document